Status:

COMPLETED

Assessing the Performance of Artificial Intelligence (AI)-Augmented Electronic Health Record (EHR) Data Abstraction for Clinical Trial Patient Screening

Lead Sponsor:

University of Pennsylvania

Collaborating Sponsors:

Mendel AI

Conditions:

Cancer

Eligibility:

All Genders

Brief Summary

Identifying eligible patients is a key process in the clinical trial enterprise. Currently, this process relies on time-intensive manual chart review, creating a rate-limiting step for trial participa...

Detailed Description

The objective of this study is to assess and compare the accuracy and efficiency of three different approaches to abstracting clinical data used to identify oncology patients who meet the inclusion cr...

Eligibility Criteria

Inclusion

  • Diagnosis of colorectal or non-small cell lung cancer.
  • A minimum of 5 patient documents in the Mendel database.
  • Most recent document was within 5 years from the time of data extraction.

Exclusion

  • None.

Key Trial Info

Start Date :

August 18 2023

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 12 2024

Estimated Enrollment :

355 Patients enrolled

Trial Details

Trial ID

NCT06561217

Start Date

August 18 2023

End Date

July 12 2024

Last Update

July 25 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Emory University

Atlanta, Georgia, United States, 30307

2

University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19104